Corpus ID: 198292733

Patients and Caregivers Perspectives on a Mobile App that Tracks Adherence and Outcomes in Children with Growth Disorders Treated with Recombinant Human Growth Hormone (r-hGH)

@inproceedings{McNally2018PatientsAC,
  title={Patients and Caregivers Perspectives on a Mobile App that Tracks Adherence and Outcomes in Children with Growth Disorders Treated with Recombinant Human Growth Hormone (r-hGH)},
  author={M. McNally and F. Long and Henry Poskitt and J. Cancela and E. Koledova and J. S. Castro},
  year={2018}
}
Presented at ESPE 2018; September 27-September 29, 2018; Athens, Greece. • easypodTM is an electromechanical autoinjector used for the administration of recombinant human growth hormone (r-hGH; Saizen®,Merck KGaA, Darmstadt, Germany). • Healthcare professionals (HCPs) receive adherence information on Saizen® treatment via data wirelessly transferred from the easypodTM device to the web-based eHealth platform easypodTM Connect. • The growlinkTM mobile app is being developed in order to empower… Expand